Results 81 to 90 of about 74,841 (314)

TREATMENT OF PARADOXICAL VOCAL FOLD MOTION IN A 12-YEAR-OLD PATIENT WITH PATAU’S SYNDROME

Euromediterranean Biomedical Journal, 2019
We describe the case of a 12-year-old girl with paradoxical vocal fold motion (PVFM) secondary to partial Patau’s syndrome, successfully treated with botulinum toxin A (BTX-A) injection to the vocal folds.
Viviana Nicastro
doaj   +1 more source

From Disability to Diagnosis: Baseline Findings from the Calgary Functional Movement Disorder Registry

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Functional movement disorder (FMD), a subtype of functional neurological disorder, is a complex neuropsychiatric syndrome characterized by inconsistent and incongruent motor symptoms. Despite its relatively high prevalence, FMD remains associated with delayed diagnosis, significant disability, and limited evidence to guide ...
Andrea Soumbasis, Brian Steele, Megan Howlett, Kate Kain, Davide Martino, Kimberly G. Williams, Gabriela S. Gilmour   +6 more
wiley   +1 more source

Presence of Clostridium spp. and Clostridium botulinum Types A, B, E, and F in Honey

, 2023
In this study, a total of 300 honey samples were collected from different sale points in Diyarbakir, Mardin, Batman, Mus, Siirt, Bitlis, and Bingol cities in the Eastern and Southeastern Anatolian regions of Turkiye.
Vural, Aydin, Aydın VURAL, Guran, Husnu Sahan, Erkan, Mehmet Emin, Hüsnü Şaban GÜRAN, Mehmet Emin ERKAN   +5 more
core   +1 more source

Efficacy of IncobotulinumtoxinA (BoNT‐A) Injections in Upper Limb Task‐Specific and Position‐Dependent Tremors

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Task‐specific tremors (TST) and position‐dependent tremors (PDT) are rare isolated focal tremors that impair fine motor control with few effective treatment options. Although botulinum neurotoxin (BoNT) is effective in other tremor syndromes, its evidence in these tremor subtypes remains limited.
Elizabeth K. Boyd, Shangge Jiang, Runjie Bill Shi, Philippe Rizek   +3 more
wiley   +1 more source

Pseudo‐Dystonic Gait in a Preschool Child: Foot Posturing Contralateral to a Cuboid Fracture

Movement Disorders Clinical Practice, EarlyView.
Allison J. Chirigos, Donald L. Gilbert, Barbara E. Hallinan, Jes Marchbank, Alberto J. Espay   +4 more
wiley   +1 more source

Botulinum Toxin Injection for Masseteric Hypertrophy Using 6 Point Injection Technique – A Case Report. Proposal of a Clinical Technique to Quantify Prognosis

Clinical, Cosmetic and Investigational Dentistry, 2023
Neha N Rathod, Rubin S John Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, 600077, IndiaCorrespondence: Rubin S
Rathod NN, John RS
doaj  

Therapeutic Uses and Efficacy of Botulinum Toxin in Orofacial Medicine

In recent years, the applications of botulinum toxin therapy have expanded explosively, including for diseases of the oral region. The aim of the following reprint is to provide a summary of the current status and the latest information on botulinum ...

core   +1 more source

Lower Urinary Tract Symptoms as Diagnostic Clues in Parkinsonism: A Practical Framework for Neurologists

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Lower urinary tract symptoms (LUTS) are among the most prevalent nonmotor complaints across the parkinsonian spectrum, yet they remain underutilized as diagnostic and management signals in neurology practice. Although prior reviews have characterized disease‐specific patterns of urinary dysfunction, and recent guidelines address ...
Saar Anis, Omer Anis, Abhishek Lenka, Junaid H. Siddiqui   +3 more
wiley   +1 more source

The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies

Toxins, 2017
The goal of the AntiBotABE Program was the development of recombinant antibodies that neutralize botulinum neurotoxins (BoNT) A, B and E. These serotypes are lethal and responsible for most human botulinum cases.
Christine Rasetti-Escargueil, Arnaud Avril, Sebastian Miethe, Christelle Mazuet, Yagmur Derman, Katja Selby, Philippe Thullier, Thibaut Pelat, Remi Urbain, Alexandre Fontayne, Hannu Korkeala, Dorothea Sesardic, Michael Hust, Michel R. Popoff   +13 more
doaj   +1 more source

OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients. [PDF]

, 2015
Hemicrania continua is a strictly unilateral, continuous headache, typically mild to moderate in severity, with severe exacerbations commonly accompanied by cranial autonomic features and migrainous symptoms. It is exquisitely responsive to Indomethacin.
Lagrata, S, Manjit S Matharu, Matharu, MS, Correia, F., Miller, S., Matharu, M., Fernando Correia, Miller, S, Susie Lagrata, Lagrata, S., Sarah Miller, Correia, F   +11 more
core   +3 more sources